OR WAIT null SECS
Applied Biology Company has purchased the assets of LAB Research, which consists of three facilities located in Hungary, Denmark and Canada.
Applied Biology Company, the holding company of European preclinical research organization CIT Safety & Health Research Laboratories, has purchased the assets of LAB Research, which consists of three facilities located in Hungary, Denmark and Canada.
“With the acquisition of Lab Research, we seized a major opportunity to create a global player serving the pharmaceutical, biotechnology and chemical industries. At a time when the biggest industry companies are turning to global outsourcing agreements, the new CIT-LAB group will be a partner of choice thanks to its ability to carry out a broader range of studies and to provide scientific synergies between facilities,” said Dr Jean-François Le Bigot, CIT and ABC executive chairman. “LAB Research’s three centres have experienced and dedicated scientific teams and modern facilities. The three LAB Research facilities provide “general services” in non-clinical safety assessment, and each has its own specialization, such as large animals in Canada, minipigs in Denmark or inhalation and ecotoxicology in Hungary. CIT’s own expertise is in large animals, carcinogenicity, genetic toxicology, reprotoxicology and genomics/biomarkers.”
The newly created CIT-LAB group is spread over five sites in France (Evreux and Saint-Nazaire), Canada (Laval), Denmark (Lille Skensved) and Hungary (Veszprém).
For more information visit www.citox.com